UPB - Upstream Bio
Printed from CEF Radar (cefradar.com). Source: public filings at the U.S. Securities and Exchange Commission. Last checked: Nov 2, 2026, 3:57 p.m. New York time.
UPB is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.
Is anyone targeting this fund?
No - none of the investors we follow has reported owning 5% or more of this company.
What this means for you
None of the investors we follow has reported owning 5% or more of this company. Most companies are in that state.
Nothing is required of you. If that changes, the notice appears here within a day of being filed with the regulator.
What happened, and when
-
Oct 29, 2026
Decheng Capital Global Life Sciences Fund IV, L.P. sold down below 5% and stopped reporting.
Original document →
Details: all notices, events and fund facts
| Date | Investor | Stake | Type of notice |
|---|---|---|---|
| Oct 29, 2026 | Decheng Capital Global Life Sciences Fund IV, L.P. | 4.9% | Sold down below 5% |
No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.
- Run by
- not filed yet
- Fund family
- not filed yet
- Exchange
- Nasdaq
See this fund's page at the SEC →
Email me when something new is filed for UPB
Free. One email when a large investor files a notice, or when the fund announces a buy-back, a vote or a closing - usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.